OMNI is a pharmaceutical company that focuses on drug delivery technologies.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 27, 2021 | Series D | — | 1 | — | — | Detail |
Sep 29, 2017 | Series B | ¥20M | 2 | — | — | Detail |
Sep 22, 2015 | Series A | ¥10M | 2 | — | — | Detail |
Feb 19, 2013 | Angel | ¥3M | 1 | Haimen Pushi Yiyao | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Haimen Pushi Yiyao | Yes | Angel |
Zhangkelingyi | — | Series D |
Shiyao Biomedical Technology | — | Series B |
Vivo Olive Surplus HK VIII Limited | — | Series B |
Shanghai Chenshan Investment Management | — | Series A |
Shanghai Liyi Investment Management | — | Series A |